Gut Health Could Signal Parkinson’s Risk Years Before Symptoms, New UCL Study Finds
Your gut might be sending warning signs about Parkinson’s disease years — even decades — before any tremor or movement issue appears, according to new research from University College London that adds to mounting evidence linking digestive health to brain disease.
UCL researchers identified specific patterns in gut bacteria that may flag a person’s risk of developing Parkinson’s long before a clinical diagnosis, a finding that could reshape how the disease is detected and potentially slowed in its earliest stages.
What the UCL Study Examined
The team analyzed stool samples from three groups: 271 people already diagnosed with Parkinson’s, 43 people who carried a high-risk genetic variant called GBA1 but had no symptoms yet and 150 healthy individuals with no diagnosis and no GBA1 mutation. The GBA1 variant is estimated to raise Parkinson’s risk by nearly 30 times.
By comparing the three groups, researchers spotted microbial signatures that mapped to both disease status and genetic vulnerability. In other words, the bacteria in someone’s gut may not just reflect that they have Parkinson’s — they may quietly hint that the disease is on the way.
The study found those carrying the GBA1 mutation but without symptoms already show an intermediate microbial profile, suggesting early changes before disease onset. Researchers identified 176 bacterial species that differed across groups and consistent shifts across international cohorts. These patterns may help identify early risk, though the study cannot determine whether microbiome changes cause or result from Parkinson’s.
What Is GBA1?
If GBA1 is unfamiliar, you’re not alone. According to MedlinePlus: “The GBA1 gene provides instructions for making an enzyme called lysosomal acid glucosylceramidase. This enzyme is active in lysosomes, which are structures inside cells that act as recycling centers. Lysosomes use digestive enzymes to break down toxic substances, digest bacteria that invade the cell, and recycle worn-out cell components.”
Think of it as cellular housekeeping. When the system breaks down, problems pile up — and Parkinson’s risk climbs.
Building on Earlier Research
The UCL findings build on a foundational 2015 study, which also showed that people with the condition have a noticeably different microbiome than healthy peers.
That earlier work found reduced levels of bacteria that produce short-chain fatty acids — molecules that help maintain the gut lining and tamp down inflammation — and a higher relative abundance of bacterial groups tied to inflammatory activity. The microbiome changes could plausibly affect immune signaling, gut barrier function and inflammatory pathways already implicated in Parkinson’s.
The 2015 authors noted their findings were correlational and couldn’t establish whether microbial changes caused the disease or came along for the ride. The new UCL work extends the question into the pre-symptomatic stage.
The Scope of Parkinson’s in America
An estimated 1.1 million people in the U.S. are living with Parkinson’s disease, a figure projected to climb to 1.2 million by 2030, according to the Parkinson’s Foundation. Parkinson’s is the second-most common neurodegenerative disease after Alzheimer’s.
A few more numbers worth knowing:
- Nearly 90,000 people in the U.S. are diagnosed with Parkinson’s each year
- More than 10 million people worldwide are estimated to be living with it
- About 4% of people with Parkinson’s are diagnosed before age 50
- Men are 1.5 times more likely to develop it than women
The Gut Connection Many Don’t Realize
The Parkinson’s Foundation puts it this way: “About 80% of people with Parkinson’s experience gastrointestinal (GI) issues. These issues can develop up to 10-20 years before a PD diagnosis. Therefore, the gut microbiome is a ripe target for future treatments that could potentially stop or slow PD progression at an early stage.”
The foundation notes the gut microbiome is complex and unique to each person. For people dealing with GI symptoms, suggested starting points are practical: more fiber-rich foods, fewer starchy ones, more fluids and more movement. Because probiotic and prebiotic supplements affect people differently, the foundation advises talking to a doctor first.
There’s another wrinkle for those managing the disease. Parkinson’s can cause gastroparesis — a slowed ability to empty the stomach — which changes how medications are absorbed. Standard treatments like carbidopa/levodopa may take longer to kick in or feel less effective when GI issues are in play. The medications themselves can also reshape the gut microbiome, creating a feedback loop researchers are still working to understand.
The bigger takeaway from this wave of research: gut health isn’t just about digestion. It may be one of the earliest windows into what’s happening inside the brain — sometimes decades before any clinical sign emerges.
This article was created by content specialists using various tools, including AI.
